A major breakthrough in cancer study is emerging with the use of VHH fragments to re-engage mutated p53. This vital tumor protector protein is frequently disabled in several kinds of tumors, causing uncontrolled cell https://thejillist.com/story12399289/nanobodies-restore-the-p53-protein-the-promising-approach-for-tumor-management